Matches in Wikidata for { <http://www.wikidata.org/entity/Q63336051> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q63336051 description "clinical trial" @default.
- Q63336051 description "ensayu clínicu" @default.
- Q63336051 description "klinisch onderzoek" @default.
- Q63336051 description "клінічне випробування" @default.
- Q63336051 name "A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology." @default.
- Q63336051 type Item @default.
- Q63336051 label "A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology." @default.
- Q63336051 prefLabel "A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology." @default.
- Q63336051 P1132 Q63336051-68ABE29B-77B6-434E-8D10-A03732AE5D49 @default.
- Q63336051 P1476 Q63336051-312F4134-21B3-417A-881B-0054630FB1DA @default.
- Q63336051 P17 Q63336051-016734D2-2208-44B4-A431-97CB7F13E644 @default.
- Q63336051 P17 Q63336051-B8E036D4-52E1-4BB4-BD69-26D08064398A @default.
- Q63336051 P17 Q63336051-C416EDB5-5E16-4272-B267-4E6E9E194351 @default.
- Q63336051 P17 Q63336051-E27F4ABC-3024-4945-9491-2E4213CBA796 @default.
- Q63336051 P2899 Q63336051-406F70ED-A68E-4BD4-BCEA-F606B9509D48 @default.
- Q63336051 P3098 Q63336051-8C803953-C760-4F4B-9BC1-E7A6E1FA22DF @default.
- Q63336051 P31 Q63336051-815E88F7-FF0A-407D-B55A-94A5F9428332 @default.
- Q63336051 P4844 Q63336051-37A3ADB9-502A-48FD-B679-1A677ECCAF97 @default.
- Q63336051 P4844 Q63336051-55CB467C-9028-4E68-8C96-1CCC52632024 @default.
- Q63336051 P4844 Q63336051-BE095599-4804-403E-84AE-C40DA148540C @default.
- Q63336051 P580 Q63336051-482FB2AB-F290-45A9-8EEA-B3A1C4812530 @default.
- Q63336051 P582 Q63336051-0DD8BD0A-0905-41E9-A352-1DC1287FB335 @default.
- Q63336051 P6099 Q63336051-4B88686F-53FC-4215-954D-D11AADFC828C @default.
- Q63336051 P8363 Q63336051-4C3F77F3-7271-4E13-BA6F-EBF51F4F62CC @default.
- Q63336051 P859 Q63336051-6ECE786C-7695-4171-AD23-4A4330202B96 @default.
- Q63336051 P1132 "+16" @default.
- Q63336051 P1476 "LUME-Lung 3: A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology" @default.
- Q63336051 P17 Q145 @default.
- Q63336051 P17 Q29 @default.
- Q63336051 P17 Q38 @default.
- Q63336051 P17 Q55 @default.
- Q63336051 P2899 "+18" @default.
- Q63336051 P3098 "NCT01346540" @default.
- Q63336051 P31 Q30612 @default.
- Q63336051 P4844 Q15149723 @default.
- Q63336051 P4844 Q412415 @default.
- Q63336051 P4844 Q414143 @default.
- Q63336051 P580 "2011-04-14T00:00:00Z" @default.
- Q63336051 P582 "2013-04-25T00:00:00Z" @default.
- Q63336051 P6099 Q5452194 @default.
- Q63336051 P8363 Q78089383 @default.
- Q63336051 P859 Q699532 @default.